Clinical trial · Observational
A Study of Nasopharyngeal Carcinoma From Guangdong
A Prospective Cohort Study of Nasopharyngeal Carcinoma to Establish Prognostic Models, to Discover Toxicity Associated Predictors and to Validate Randomized Trials in Clinical Practice
NCT03003182CI-TRIAL-00028140unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Cancer | Malignant Nasopharyngeal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- in clinical trials
- label
- out of clinical trials
Primary outcomes (1)
- measure
- overall survival
- timeFrame
- 3-years
Secondary outcomes (1)
- measure
- Number of participants with treatment-related acute adverse events as assessed by CTCAE v4.0
- timeFrame
- 30-days
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * histological confirmed nasopharyngeal carcinoma; * scanned by magnetic resonance imaging from calvaria vertex to clavicles before treatment; * pretreatment Epstein-Barr virus deoxyribonucleic acid copy number is available; * irradiated with intensity-modulated radiotherapy; Exclusion Criteria: * finishing anticancer therapy in two or more hospitals; * pregnancy or lactation; * diagnosed with other sort of cancer before or during the treatment.
References
Publications (1)
- DERIVEDYang SS, Wu YS, Pang YJ, Xiao SM, Zhang BY, Liu ZQ, Chen EN, Zhang X, OuYang PY, Xie FY. Development and validation of radiologic scores for guiding individualized induction chemotherapy in T3N1M0 nasopharyngeal carcinoma. Eur Radiol. 2022 Jun;32(6):3649-3660. doi: 10.1007/s00330-021-08460-1. Epub 2022 Jan 6. PMID 34989842